Option Care Health (OPCH) Stock Forecast & Price Target

Compare

507 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

OPCH Analyst Ratings

Strong Buy

5 Buy

1 Hold

0 Sell

Based on 6 analysts giving stock ratings to

Option

Care Health

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

OPCH Stock 12 Month Forecast

Average Price Target

$36.50

▲(32.73% Upside)

Based on 6 Wall Street analysts offering 12 month price targets for Option Care Health in the last 3 months. The average price target is $36.50 with a high forecast of $40.00 and a low forecast of $30.00. The average price target represents a 32.73% change from the last price of $27.50.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"22":"$22","41":"$41","26.75":"$26.8","31.5":"$31.5","36.25":"$36.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":40,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$40.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":36.5,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$36.50</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":30,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$30.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[22,26.75,31.5,36.25,41],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jan<br/>2025","6":"Apr<br/>2025","9":"Jul<br/>2025","12":"Oct<br/>2025","25":"Oct<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,27.24,28.22153846153846,29.20307692307692,30.184615384615384,31.166153846153847,32.14769230769231,33.129230769230766,34.11076923076923,35.09230769230769,36.073846153846155,37.05538461538461,38.036923076923074,39.01846153846154,{"y":40,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,27.24,27.95230769230769,28.664615384615384,29.376923076923077,30.089230769230767,30.80153846153846,31.513846153846153,32.22615384615385,32.93846153846154,33.65076923076923,34.363076923076925,35.075384615384614,35.78769230769231,{"y":36.5,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,27.24,27.45230769230769,27.664615384615384,27.876923076923077,28.089230769230767,28.30153846153846,28.513846153846153,28.726153846153846,28.93846153846154,29.15076923076923,29.363076923076925,29.575384615384614,29.787692307692307,{"y":30,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":30.15,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":24.11,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":24.12,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":23.2,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":30.92,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":33.5,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":34.95,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":32.17,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":31.86,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 28,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":31.95,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":28.26,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":28.44,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":27.24,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$40.00

Average Price Target$36.50

Lowest Price Target$30.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Charles Rhyee

TD Cowen

$30

Hold

9.09%

Upside

Initiated

10/02/25

Option Care Health: Strong Market Position and Financials Balanced by Lack of Near-Term CatalystsWe initiate coverage of Option Care Health (OPCH) with a Hold rating and $30 PT. OPCH is the leading home and alt. site infusion provider with exposure to specialty and a strong B/S to support cap. deployment. While we think OPCH can hit its LT growth targets, we also think this is baked into consensus ests. Combining this with a lack of obvious catalysts, we believe a Hold rating is appropriate.

Rosa Clinessa

TR | OpenAI - 4o

$31→$30

Hold

9.09%

Upside

Downgraded

09/24/25

AI Generated ArticleAI Generated Article

A.J. Rice

UBS

$40

Buy

45.45%

Upside

Reiterated

09/23/25

Option Care Health (OPCH) Receives a Buy from UBSUBS analyst AJ Rice reiterated a Buy rating and $40.00 price target on Option Care Health (NASDAQ: OPCH).

Michael Petusky

Barrington

$38

Buy

38.18%

Upside

Reiterated

09/23/25

Option Care Health: Strategic Positioning and Growth Potential Drive Buy RatingWe are very bullish on this effort and see it as a low-risk investment that raises both the company’s clinical reputation and reimbursement levels.

David S Macdonald

Truist Financial

―

Buy

―

Reiterated

08/21/25

Analysts Offer Insights on Healthcare Companies: Option Care Health (NASDAQ: OPCH) and Zoetis (NYSE: ZTS)

Matt Larew

William Blair

―

Buy

―

Reiterated

08/20/25

William Blair Sticks to Their Buy Rating for Option Care Health (OPCH)

Constantine Davides

Citizens JMP

$36→$38

Buy

38.18%

Upside

Reiterated

07/31/25

Option Care Health price target raised to $38 from $36 at Citizens JMPOption Care Health price target raised to $38 from $36 at Citizens JMP

Joanna Gajuk

Bank of America Securities

―

Buy

―

Reiterated

05/14/25

Bank of America Securities Remains a Buy on Option Care Health (OPCH)

Lisa Gill

J.P. Morgan

―

Buy

―

Reiterated

04/11/25

Option Care Health: Diversified Revenue Streams Mitigate Impact of Vyvgart Approval, Reinforcing Buy Rating

Brian Tanquilut

Jefferies

$40

Buy

45.45%

Upside

Reiterated

04/11/25

Minimal Impact of VYVGART Approval on Option Care Health Justifies Buy Rating

Jamie Perse

Goldman Sachs

$25→$35

Hold

27.27%

Upside

Reiterated

02/28/25

Option Care Health (OPCH) PT Raised to $35 at Goldman SachsGoldman Sachs analyst Jamie Perse raised the price target on Option Care Health (NASDAQ: OPCH) to $35.00 (from $25.00) while maintaining a Neutral rating.

Pito Chickering

Deutsche Bank

$36→$30

Buy

9.09%

Upside

Reiterated

10/31/24

Option Care Health (OPCH) PT Lowered to $30 at Deutsche BankDeutsche Bank analyst Pito Chickering lowered the price target on Option Care Health (NASDAQ: OPCH) to $30.00 (from $36.00) while maintaining a Buy rating.

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Charles Rhyee

TD Cowen

$30

Hold

9.09%

Upside

Initiated

10/02/25

Rosa Clinessa

TR | OpenAI - 4o

$31→$30

Hold

9.09%

Upside

Downgraded

09/24/25

AI Generated ArticleAI Generated Article

A.J. Rice

UBS

$40

Buy

45.45%

Upside

Reiterated

09/23/25

Option Care Health (OPCH) Receives a Buy from UBSUBS analyst AJ Rice reiterated a Buy rating and $40.00 price target on Option Care Health (NASDAQ: OPCH).

Michael Petusky

Barrington

$38

Buy

38.18%

Upside

Reiterated

09/23/25

David S Macdonald

Truist Financial

―

Buy

―

Reiterated

08/21/25

Analysts Offer Insights on Healthcare Companies: Option Care Health (NASDAQ: OPCH) and Zoetis (NYSE: ZTS)

Matt Larew

William Blair

―

Buy

―

Reiterated

08/20/25

William Blair Sticks to Their Buy Rating for Option Care Health (OPCH)

Constantine Davides

Citizens JMP

$36→$38

Buy

38.18%

Upside

Reiterated

07/31/25

Option Care Health price target raised to $38 from $36 at Citizens JMPOption Care Health price target raised to $38 from $36 at Citizens JMP

Joanna Gajuk

Bank of America Securities

―

Buy

―

Reiterated

05/14/25

Bank of America Securities Remains a Buy on Option Care Health (OPCH)

Lisa Gill

J.P. Morgan

―

Buy

―

Reiterated

04/11/25

Option Care Health: Diversified Revenue Streams Mitigate Impact of Vyvgart Approval, Reinforcing Buy Rating

Brian Tanquilut

Jefferies

$40

Buy

45.45%

Upside

Reiterated

04/11/25

Minimal Impact of VYVGART Approval on Option Care Health Justifies Buy Rating

Jamie Perse

Goldman Sachs

$25→$35

Hold

27.27%

Upside

Reiterated

02/28/25

Pito Chickering

Deutsche Bank

$36→$30

Buy

9.09%

Upside

Reiterated

10/31/24

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Option Care Health

1 Month

xxx

Success Rate

18/27 ratings generated profit

Average Return

+2.25%

reiterated a xxx

rating last month

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 1 Month would result in 66.67% of your transactions generating a profit, with an average return of +2.25% per trade.

3 Months

xxx

Success Rate

13/27 ratings generated profit

Average Return

+2.53%

reiterated a xxx

rating last month

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 48.15% of your transactions generating a profit, with an average return of +2.53% per trade.

1 Year

David S MacdonaldTruist Financial

Success Rate

17/27 ratings generated profit

Average Return

+8.30%

reiterated a buy rating last month

Copying David S Macdonald's trades and holding each position for 1 Year would result in 62.96% of your transactions generating a profit, with an average return of +8.30% per trade.

2 Years

xxx

Success Rate

20/35 ratings generated profit

Average Return

+21.89%

reiterated a xxx

rating 12 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 57.14% of your transactions generating a profit, with an average return of +21.89% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

OPCH Analyst Recommendation Trends

Rating

Jun 25

Jul 25

Aug 25

Sep 25

Oct 25

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, OPCH has received 8 Buy Ratings, 4 Hold Ratings, and 0 Sell Ratings. OPCH average Analyst price target in the past 3 months is 36.50.

Each month's total comprises the sum of three months' worth of ratings.

OPCH Financial Forecast

OPCH Earnings Forecast

Next quarter’s earnings estimate for OPCH is $0.43 with a range of $0.41 to $0.44. The previous quarter’s EPS was $0.41. OPCH beat its EPS estimate 0.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 57.09% of the time in the same period. In the last calendar year OPCH has Preformed in-line its overall industry.

OPCH Sales Forecast

Next quarter’s sales forecast for OPCH is $1.41B with a range of $1.37B to $1.44B. The previous quarter’s sales results were $1.42B. OPCH beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 47.55% of the time in the same period. In the last calendar year OPCH has Preformed in-line its overall industry.

OPCH Stock Forecast FAQ

What is OPCH’s average 12-month price target, according to analysts?

Based on analyst ratings, Option Care Health’s 12-month average price target is 36.50.

What is OPCH’s upside potential, based on the analysts’ average price target?

Option Care Health has 32.73% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is OPCH a Buy, Sell or Hold?

Option Care Health has a consensus rating of Strong Buy which is based on 5 buy ratings, 1 hold ratings and 0 sell ratings.

What is Option Care Health’s price target?

The average price target for Option Care Health is 36.50. This is based on 6 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $40.00 ,the lowest forecast is $30.00. The average price target represents 32.73% Increase from the current price of $27.5.

What do analysts say about Option Care Health?

Option Care Health’s analyst rating consensus is a Strong Buy. This is based on the ratings of 6 Wall Streets Analysts.

How can I buy shares of OPCH?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing

Option Care Health (OPCH) Stock Forecast & Price Target

OPCH Analyst Ratings

OPCH Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Option Care Health

OPCH Analyst Recommendation Trends

OPCH Financial Forecast

OPCH Earnings Forecast

OPCH Sales Forecast

OPCH Stock Forecast FAQ

Become an Expert with TipRanks Premium

Detailed List of Analyst Forecasts